Semaglutide is perfectly tolerated with no possibility of hypoglycaemia in monotherapy but suffers from gastrointestinal adverse results. A large populace afflicted with COVID-19 infection were being diabetic; thus use of semaglutide in diabetes and CV sufferers would be greatly supportive in keeping well being care procedure through this pandemic circumstance. https://robertv000hsd2.theobloggers.com/profile